WEE1

UniProt ID: F6TY09
Organism: Equus caballus
Review Status: IN PROGRESS
πŸ“ Provide Detailed Feedback

Gene Description

WEE1 is a conserved protein tyrosine kinase that inhibits CDK activity and restrains the G2/M transition. The horse protein closely matches full-length human WEE1 across both regulatory and catalytic regions, supporting nuclear checkpoint activity. It is distinct from the WEE2 paralog associated with oocyte meiotic regulation.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000166 nucleotide binding
IEA
GO_REF:0000104
ACCEPT
Summary: The intact WEE1 kinase retains nucleotide/cofactor-dependent catalysis.
Reason: Full-length conservation includes the kinase domain and ATP-binding/catalytic sites, supporting these biochemical requirements independently of electronic label agreement.
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0000278 mitotic cell cycle
IEA
GO_REF:0000002
ACCEPT
Summary: Conserved WEE1 is a negative regulator of mitotic entry.
Reason: The full-length horse ortholog supports transfer of the human CDK-inhibitory checkpoint mechanism.
Supporting Evidence:
PMID:7743995
WEE1Hu plays a role in inhibiting mitosis before M phase by phosphorylating cyclin B1-Cdc2.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0000287 magnesium ion binding
IEA
GO_REF:0000002
ACCEPT
Summary: The intact WEE1 kinase retains nucleotide/cofactor-dependent catalysis.
Reason: Full-length conservation includes the kinase domain and ATP-binding/catalytic sites, supporting these biochemical requirements independently of electronic label agreement.
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0004672 protein kinase activity
IEA
GO_REF:0000120
MODIFY
Summary: The generic catalytic term can be resolved to protein tyrosine kinase activity.
Reason: The near-identical full-length WEE1 sequence and primary substrate assays support a specific tyrosine kinase assignment.
Proposed replacements: protein tyrosine kinase activity
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0004674 protein serine/threonine kinase activity
IEA
GO_REF:0000120
MODIFY
Summary: The established WEE1 substrate specificity is tyrosine phosphorylation.
Reason: These electronic assignments appear to inherit Ser/Thr-family fold terminology. The close human ortholog directly phosphorylates CDK1 Tyr15, not Thr14. Replace with the established physiological tyrosine activity; this does not claim every possible in-vitro serine autophosphorylation reaction has been excluded.
Proposed replacements: protein tyrosine kinase activity
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0004713 protein tyrosine kinase activity
IBA
GO_REF:0000033
ACCEPT
Summary: The intact horse WEE1 supports non-receptor tyrosine kinase activity.
Reason: Full-length sequence conservation and the experimentally characterized human CDK substrate provide independent biological support.
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0004713 protein tyrosine kinase activity
IEA
GO_REF:0000120
ACCEPT
Summary: The intact horse WEE1 supports non-receptor tyrosine kinase activity.
Reason: Full-length sequence conservation and the experimentally characterized human CDK substrate provide independent biological support.
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0004715 non-membrane spanning protein tyrosine kinase activity
IEA
GO_REF:0000120
ACCEPT
Summary: The intact horse WEE1 supports non-receptor tyrosine kinase activity.
Reason: Full-length sequence conservation and the experimentally characterized human CDK substrate provide independent biological support.
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0005524 ATP binding
IEA
GO_REF:0000120
ACCEPT
Summary: The intact WEE1 kinase retains nucleotide/cofactor-dependent catalysis.
Reason: Full-length conservation includes the kinase domain and ATP-binding/catalytic sites, supporting these biochemical requirements independently of electronic label agreement.
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0005634 nucleus
IBA
GO_REF:0000033
ACCEPT
Summary: Nuclear WEE1 checkpoint activity is strongly conserved.
Reason: Human localization and full-length horse conservation support the nuclear pool.
Supporting Evidence:
PMID:8348613
the human wee1-like tyrosine kinase is a nuclear protein that ensures the completion of DNA replication prior to mitosis
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0005634 nucleus
IEA
GO_REF:0000120
ACCEPT
Summary: Nuclear WEE1 checkpoint activity is strongly conserved.
Reason: Human localization and full-length horse conservation support the nuclear pool.
Supporting Evidence:
PMID:8348613
the human wee1-like tyrosine kinase is a nuclear protein that ensures the completion of DNA replication prior to mitosis
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0005730 nucleolus
IEA
GO_REF:0000107
UNDECIDED
Summary: Nuclear residence does not resolve a specific nucleolar pool.
Reason: This transfer needs the underlying human HPA image assessment or horse-specific subnuclear imaging.
Supporting Evidence:
PMID:8348613
the human wee1-like tyrosine kinase is a nuclear protein that ensures the completion of DNA replication prior to mitosis
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0005737 cytoplasm
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: A cytoplasmic WEE1 pool is compatible with conserved localization regulation.
Reason: Retain the phylogenetic/ortholog-supported additional pool without making it the principal site of the nuclear checkpoint reaction.
Supporting Evidence:
PMID:8348613
the human wee1-like tyrosine kinase is a nuclear protein that ensures the completion of DNA replication prior to mitosis
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0005737 cytoplasm
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: A cytoplasmic WEE1 pool is compatible with conserved localization regulation.
Reason: Retain the phylogenetic/ortholog-supported additional pool without making it the principal site of the nuclear checkpoint reaction.
Supporting Evidence:
PMID:8348613
the human wee1-like tyrosine kinase is a nuclear protein that ensures the completion of DNA replication prior to mitosis
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0010972 negative regulation of G2/M transition of mitotic cell cycle
IBA
GO_REF:0000033
ACCEPT
Summary: Conserved WEE1 is a negative regulator of mitotic entry.
Reason: The full-length horse ortholog supports transfer of the human CDK-inhibitory checkpoint mechanism.
Supporting Evidence:
PMID:7743995
WEE1Hu plays a role in inhibiting mitosis before M phase by phosphorylating cyclin B1-Cdc2.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0010972 negative regulation of G2/M transition of mitotic cell cycle
IEA
GO_REF:0000107
ACCEPT
Summary: Conserved WEE1 is a negative regulator of mitotic entry.
Reason: The full-length horse ortholog supports transfer of the human CDK-inhibitory checkpoint mechanism.
Supporting Evidence:
PMID:7743995
WEE1Hu plays a role in inhibiting mitosis before M phase by phosphorylating cyclin B1-Cdc2.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0016301 kinase activity
IEA
GO_REF:0000104
MODIFY
Summary: The generic catalytic term can be resolved to protein tyrosine kinase activity.
Reason: The near-identical full-length WEE1 sequence and primary substrate assays support a specific tyrosine kinase assignment.
Proposed replacements: protein tyrosine kinase activity
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0016740 transferase activity
IEA
GO_REF:0000104
MODIFY
Summary: The generic catalytic term can be resolved to protein tyrosine kinase activity.
Reason: The near-identical full-length WEE1 sequence and primary substrate assays support a specific tyrosine kinase assignment.
Proposed replacements: protein tyrosine kinase activity
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0106310 protein serine kinase activity
IEA
GO_REF:0000116
MODIFY
Summary: The established WEE1 substrate specificity is tyrosine phosphorylation.
Reason: These electronic assignments appear to inherit Ser/Thr-family fold terminology. The close human ortholog directly phosphorylates CDK1 Tyr15, not Thr14. Replace with the established physiological tyrosine activity; this does not claim every possible in-vitro serine autophosphorylation reaction has been excluded.
Proposed replacements: protein tyrosine kinase activity
Supporting Evidence:
PMID:8428596
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.

Core Functions

Phosphorylates inhibitory CDK tyrosine to restrain mitotic entry.

Supporting Evidence:
  • PMID:8428596
    purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
  • PMID:7743995
    WEE1Hu plays a role in inhibiting mitosis before M phase by phosphorylating cyclin B1-Cdc2.
  • PMID:8348613
    the human wee1-like tyrosine kinase is a nuclear protein that ensures the completion of DNA replication prior to mitosis
  • file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
    share 95.4% identity among 646 paired residues.

References

Loading supporting content…

Download this section (compressed HTML)

External Prediction Reviews

These computational predictions are reviewed separately from the GOA annotation set used for this review. The assessments below are from this project and do not constitute official GO annotations or endorsement by GO/UniProt. They are not included in the existing annotation review above.

ProtNLM2 External predictions

View prediction review YAML Β· WEE1-protnlm-predictions-review.yaml Β· Review status: COMPLETE

The intact WEE1 sequence supports nuclear CDK phosphorylation; oocyte-specific predictions require distinction from WEE2.

Source documents: projects/PROTNLM_EVALUATION/mammal-benchmark/horse40-predictions.csv Β· projects/PROTNLM_EVALUATION/mammal-benchmark/predictions.jsonl.gz Β· projects/PROTNLM_EVALUATION/mammal-benchmark/paired-sequences/WEE1.json

Review score: 2 = concordant with evidence; 1 = uncertain; 0 = discordant with evidence. This is an assessment score, not a model probability.

GO:0060631 regulation of meiosis I GO_BP
UNC β€” Uncertain Review score: 1/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: WEE1 is a conserved CDK-inhibitory kinase, but mammalian oocyte studies distinguish somatic WEE1 from WEE2/Wee1B. A mitotic checkpoint mechanism does not automatically establish regulation of meiosis I. Broad meiotic participation cannot be excluded without horse-specific expression and perturbation evidence. Later Wee2 knockout mice retain fertility, reinforcing that this evidence should not be generalized to absolute indispensability or absence of compensation.
Supporting Evidence:
  • PMID:7743995: "WEE1Hu plays a role in inhibiting mitosis before M phase by phosphorylating cyclin B1-Cdc2."
  • PMID:21454751: "Wee1B mRNA was continuously expressed during the meiotic cell cycle and was replaced by somatic Wee1 (hereafter termed Wee1A) during the 2- or 4-cell embryo mitotic divisions"
  • file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md: "share 95.4% identity among 646 paired residues."
  • PMID:37527245: "Wee2 loss-of-function is likely complicated by biological redundancies with other proteins co-expressed in oocytes."
GO:0005654 nucleoplasm GO_CC
COR β€” Correct novel prediction Review score: 2/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: Human experiments place the soluble checkpoint kinase in the nucleus. Full-length horse sequence conservation supports nucleoplasmic activity; this is more specific than the frozen horse nucleus annotation.
Supporting Evidence:
GO:0005886 plasma membrane GO_CC
UNC β€” Uncertain Review score: 1/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: The characterized WEE1 checkpoint pool is nuclear, with additional cytoplasmic annotations. No primary evidence retrieved establishes plasma-membrane recruitment of the selected horse protein. A soluble kinase can associate peripherally with a membrane, so absence of a transmembrane helix does not refute the prediction.
Supporting Evidence:
GO:0035038 female pronucleus assembly GO_BP
UNC β€” Uncertain Review score: 1/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: The mouse egg-activation experiment distinguishes WEE2/Wee1B depletion, which blocks pronucleus formation, from WEE1/Wee1A depletion, which does not in that assay. The selected horse sequence is a close full-length WEE1 match, making paralog transfer a plausible explanation. However, differential necessity does not exclude participation, and later Wee2 knockout mice retain substantial fertility with possible compensation. Without horse oocyte expression and perturbation evidence, this specific biological-process prediction remains uncertain rather than definitively refuted.
Supporting Evidence:
  • PMID:21454751: "Wee1B knockdown oocytes failed to form pronuclei, whereas oocytes injected with control, Myt1, or Wee1A MO were correctly activated"
  • PMID:21454751: "Wee1B mRNA was continuously expressed during the meiotic cell cycle and was replaced by somatic Wee1 (hereafter termed Wee1A) during the 2- or 4-cell embryo mitotic divisions"
  • file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md: "share 95.4% identity among 646 paired residues."
  • PMID:37527245: "Wee2 loss-of-function is likely complicated by biological redundancies with other proteins co-expressed in oocytes."
GO:0006468 protein phosphorylation GO_BP
COR β€” Correct novel prediction Review score: 2/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: Protein phosphorylation follows directly from the conserved WEE1 tyrosine-kinase reaction. This is correct but broad relative to its specific CDK-inhibitory mechanism.
Supporting Evidence:
GO:0042327 positive regulation of phosphorylation GO_BP
UNC β€” Uncertain Review score: 1/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: WEE1 catalyzes inhibitory CDK phosphorylation, which supports protein phosphorylation. A separate positive-regulation-of-phosphorylation process requires identifying the regulated reaction; the direct catalytic reaction alone does not establish that regulatory relationship, and effects on downstream CDK phosphorylation are inhibitory.
Supporting Evidence:
GO:0007143 female meiotic nuclear division GO_BP
UNC β€” Uncertain Review score: 1/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: Mammalian studies identify WEE2/Wee1B as the oocyte-enriched paralog, whereas this horse sequence is WEE1. The broad female-meiosis term is not validated by conserved kinase activity alone. Redundancy and species-specific expression leave possible participation unresolved rather than proving absence. Later Wee2 knockout mice retain fertility, reinforcing that this evidence should not be generalized to absolute indispensability or absence of compensation.
Supporting Evidence:
  • PMID:21454751: "Wee1B mRNA was continuously expressed during the meiotic cell cycle and was replaced by somatic Wee1 (hereafter termed Wee1A) during the 2- or 4-cell embryo mitotic divisions"
  • PMID:21454751: "Wee1B knockdown oocytes failed to form pronuclei, whereas oocytes injected with control, Myt1, or Wee1A MO were correctly activated"
  • file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md: "share 95.4% identity among 646 paired residues."
  • PMID:37527245: "Wee2 loss-of-function is likely complicated by biological redundancies with other proteins co-expressed in oocytes."

Deep Research

OpenScientist

(WEE1-hypotheses/horse40-female-pronucleus-assembly/openscientist.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(WEE1-notes.md)

Loading supporting content…

Download this section (compressed HTML)

Bioinformatics Results

(RESULTS.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)